Clinical Trial

A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the safety and efficacy of GenSci048 for moderate to severe endometriosis-associated pain treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-06.
Status change: Not Yet Recruiting → Recruiting 2025-08-07
Trial Details
NCT Number NCT06963177
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Endometriosis-related Pain
Enrollment 200 participants
Start Date 2025-05-26
Primary Completion 2028-05-15 (estimated)
Study Completion 2030-01-06 (estimated)
Updated on ClinicalTrials.gov 2025-08-12